Ashlee Amborn says she conceived one month into GLP-1 use for PMOS. A review hints at a fertility link, but doctors say to stop the drug about two months before trying.
Recap by typeshit. Full story at ABC7 Chicago.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Yale Medicine says 5% to 10% of people on GLP-1 weight loss drugs see little result, and points to diet as one factor that can blunt the effect.
24:26
A doctor's explainer sorting peptides into eight broad categories. An evergreen overview for anyone still learning the basics.
Across 73,592 matched pairs, starting a GLP-1 drug instead of a DPP-4 inhibitor was linked to slower frailty and a 13% lower fall rate.
A short explainer on how these drugs signal fullness and help control blood sugar, plus a note on their limits beyond obesity and diabetes care.
Loading…